These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7662192)

  • 1. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load.
    Ariyoshi K; Cham F; Berry N; Jaffar S; Sabally S; Corrah T; Whittle H
    AIDS; 1995 Jun; 9(6):555-9. PubMed ID: 7662192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
    Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
    AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
    Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT
    J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Rowland-Jones S; Sutton J; Ariyoshi K; Dong T; Gotch F; McAdam S; Whitby D; Sabally S; Gallimore A; Corrah T
    Nat Med; 1995 Jan; 1(1):59-64. PubMed ID: 7584954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
    Kundu SK; Merigan TC
    AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.
    Johnson RP; Trocha A; Yang L; Mazzara GP; Panicali DL; Buchanan TM; Walker BD
    J Immunol; 1991 Sep; 147(5):1512-21. PubMed ID: 1715361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection.
    Fan Z; Huang XL; Zheng L; Wilson C; Borowski L; Liebmann J; Gupta P; Margolick J; Rinaldo C
    J Immunol; 1997 Nov; 159(10):4973-82. PubMed ID: 9366424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death.
    Aladdin H; Ullum H; Lepri AC; Leffers H; Katzenstein T; Gerstoft J; Gjedde SB; Phillips AN; Skinhøj P; Pedersen BK
    Scand J Immunol; 1999 Aug; 50(2):223-7. PubMed ID: 10447929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections.
    Sarr AD; Popper S; Thior I; Hamel DJ; Sankalé JL; Siby T; Marlink R; Essex M; Mboup S; Kanki P
    J Hum Virol; 1999; 2(1):45-51. PubMed ID: 10200599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of T-cell cytotoxic responses in the course of HIV-1 infection.
    Zerhouni B; Sanhadji K; Touraine JL
    Thymus; 1997; 24(4):203-19. PubMed ID: 9493284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
    Betts MR; Krowka JF; Kepler TB; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger JA
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1219-28. PubMed ID: 10480635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
    Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect.
    Montoya JG; Wood R; Katzenstein D; Holodny M; Merigan TC
    J Clin Microbiol; 1993 Oct; 31(10):2692-6. PubMed ID: 7902845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins.
    Lamhamedi-Cherradi S; Culmann-Penciolelli B; Guy B; Kiény MP; Dreyfus F; Saimot AG; Sereni D; Sicard D; Lévy JP; Gomard E
    AIDS; 1992 Nov; 6(11):1249-58. PubMed ID: 1472331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.